Reuters logo
GSK invites private equity bids for older drugs -sources
May 29, 2014 / 3:15 PM / 3 years ago

GSK invites private equity bids for older drugs -sources

LONDON, May 29 (Reuters) - GlaxoSmithKline has invited private equity firms to consider making offers for a range of its older drugs, according to two people with direct knowledge of the matter.

The move is part of a reshaping of the drugmaker’s business, which also involves a major asset swap deal with Novartis .

Chief Executive Andrew Witty said last month that Britain’s biggest pharmaceuticals company could dispose of individual medicines or a broader portfolio of older established products. A GSK spokesman had no further comment on potential disposals on Thursday. (Reporting by Ben Hirschler; editing by Jon Boyle)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below